Revenue was up by 2.8% y-o-y to $74.7 million, mainly due to higher sales volume across all product segments and the expanded downstream distribution network.
UG Healthcare (SGX:8K7) has posted a lower net loss after tax of $1.4 million for 1HFY2026 ended Dec 31, 2025, an improvement of 32.5% y-o-y from $2.1 million as a result of lower foreign exchange losses.
Earnings before interest, taxes, depreciation, and amortisation (EBITA) surged more than 100% y-o-y to $3.3 million in the same period.

